BIOMAT Database Logo BIOMAT Database Logo

Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy. 2019

Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015212 Inflammatory Bowel Diseases Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS. Bowel Diseases, Inflammatory,Inflammatory Bowel Disease
D059289 Vascular Stiffness Loss of vascular ELASTICITY due to factors such as AGING; and ARTERIOSCLEROSIS. Increased arterial stiffness is one of the RISK FACTORS for many CARDIOVASCULAR DISEASES. Arterial Stiffness,Aortic Stiffness,Aortic Stiffnesses,Arterial Stiffnesses,Stiffness, Aortic,Stiffness, Arterial,Stiffness, Vascular,Vascular Stiffnesses

Related Publications

Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease.
May 2009, World journal of gastroenterology,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.
December 2015, World journal of gastroenterology,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.
December 2017, Digestive diseases and sciences,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy.
October 2017, Intestinal research,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
August 2018, JAMA neurology,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease.
January 2005, Reviews in gastroenterological disorders,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients.
October 2017, World journal of gastroenterology,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
January 2016, Scandinavian journal of gastroenterology,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy.
December 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Luca Zanoli, and Gaetano Inserra, and Maria Cappello, and Kadir Ozturk, and Pietro Castellino
Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease.
December 2003, Current gastroenterology reports,
Copied contents to your clipboard!